Forty Seven, Inc. (FTSV): Price and Financial Metrics


Forty Seven, Inc. (FTSV): $95.51

0.05 (+0.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FTSV to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

FTSV Stock Price Chart Interactive Chart >

Price chart for FTSV

FTSV Price/Volume Stats

Current price $95.51 52-week high $95.52
Prev. close $95.46 52-week low $5.53
Day low $95.46 Volume 693,900
Day high $95.52 Avg. volume 1,606,836
50-day MA $70.16 Dividend yield N/A
200-day MA $28.75 Market Cap 4.60B

Forty Seven, Inc. (FTSV) Company Bio


Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; and FSI-189, an antibody that binds to SIRPa for the treatment of solid tumors. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was founded in 2014 and is based in Menlo Park, California.


FTSV Latest News Stream


Event/Time News Detail
Loading, please wait...

FTSV Latest Social Stream


Loading social stream, please wait...

View Full FTSV Social Stream

FTSV Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 664.69%
5-year N/A
YTD N/A
2021 N/A
2020 0.00%
2019 150.45%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7205 seconds.